Skip to main content

Table 1

From: Serial monitoring of LV function following chemotherapy: assessment using advanced echocardiography and cardiovascular magnetic resonance

  LVEF (CMR)
(%)
LVEF
(Echo)
(%)
GLS
Baseline 71.9 ± 6.3 63.8 ± 5.7 -21.4 ± 2.6
3 months 66.7 ± 6.7 ** 63.5 ± 7.2 -19.5 ± 2.0 **
12 months 65.9 ± 7.0 ** 62.1 ± .9 -20.1 ± 2.6